Wastewater monitoring and AI analysis are increasingly detecting drug-resistant pathogens before clinical cases emerge, raising questions about resource allocation. Governments worldwide face choices between investing in cutting-edge predictive tools versus strengthening conventional public health infrastructure. This tension reflects broader debates about how healthcare systems should modernize.